JSM 2015 Preliminary Program

Online Program Home
My Program

Legend: Washington State Convention Center = CC, Sheraton Seattle = S, Grand Hyatt = GH and The Conference Center = TCC
* = applied session       ! = JSM meeting theme

Activity Details


435 Tue, 8/11/2015, 2:00 PM - 3:50 PM CC-613
Clinical Trial Design III — Contributed Papers
Biopharmaceutical Section
Chair(s): Wanjie Sun,
2:05 PM Evaluation of QT Correction Methods and Gender Effect on QTc Intervals Following Moxifloxacin Administration Bhavnaba Solanki, Janssen R&D ; Jayalakshmi Natarajan, Janssen R&D
2:20 PM Drug Exposure and Dose-Limiting Toxicities in Early-Phase Oncology Trials Yihua Zhao, Boehringer Ingelheim ; Shu Zhang, Boehringer Ingelheim
2:35 PM A Profile-Based Stratified Randomization and Its Application to a Double-Blind, Placebo-Controlled Clinical Trial Andrew Francis Magyar, Allergan, Inc. ; Jihao Zhou, Allergan, Inc. ; Brenda Jenkins, Allergan, Inc. ; Cornelia Haag-Molkenteller, Allergan, Inc.
2:50 PM Shelf Life Estimation: Bayesian Augmented Mixed Model Approach Maryna Ptukhina, University of Nebraska - Lincoln ; Walter Stroup, University of Nebraska - Lincoln
3:05 PM Improving the Operational Efficiency of Phase II and III Trials Jitendra Ganju, Hyperion Therapeutics
3:20 PM Bias-Corrected Estimation of Treatment Effects in Biomarker-Based Randomized Clinical Trials Kiichiro Toyoizumi, Shionogi & Co., Ltd. ; Shigeyuki Matsui, Nagoya University Graduate School of Medicine
3:35 PM Statistical Tests on Concentration-QTc Hysteresis Kuenhi Tsai, Merck ; Li Fan, Merck ; Fang Liu, Merck ; Devan Mehrotra, Merck ; Georg Ferber, Statistical Consultant




For program information, contact the JSM Registration Department or phone (888) 231-3473.

For Professional Development information, contact the Education Department.

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

2015 JSM Online Program Home